5 completed, 3 terminated, 1 recruiting. 9 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 5, Terminated 3, Recruiting 1 |
| Phase 2 | 2 | Completed 2 |
Follow Buspirone: new trials by email Literature Review of Buspirone trials Research Report on Buspirone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD Buagafuran capsules, 15mg/ capsule, Buspirone tablets, 5mg/ tablet, Buagafuran capsules mimic, 0mg/ capsule - Generalized Anxiety Disorder | Phase 3 | Recruiting | Beijing Union Pharmaceutical Factory Ltd | 410 | 2023-07-24 | 2024-02-06 |
| Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo Buspirone, Placebo - Vertigo, Autonomic Dysfunction | Phase 3 | Completed | Valenta Pharm JSC | 268 | 2022-01-28 | 2022-06-24 |
| Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease Buspirone, Placebo - Parkinson | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 99 | 2016-06-17 | 2023-04-12 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke Hypothermia, Buspirone, Pethidine - Acute Ischemic Stroke | Phase 3 | Terminated | University of Erlangen-Nürnberg Medical School | 98 | 2013-07-01 | 2019-10-02 |
| Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder Buspirone, Placebo - Autistic Disorder | Phase 2 / Phase 3 | Completed | Chugani, Diane C. | 166 | 2009-05-01 | 2016-07-26 |
| Buspirone as a Potential Treatment for Recurrent Central Apnea Acetazolamide, Buspirone - Central Apnea, Heart Failure | Phase 3 | Terminated | VA Office of Research and Development | 8 | 2008-09-01 | 2016-03-14 |
| Serotonin 1A Agonists and Cognition in Schizophrenia adjunctive treatment with buspirone, placebo - Schizophrenia, Schizoaffective Disorder | Phase 3 | Completed | Northwestern University | 60 | 2003-01-01 | 2017-06-07 |
| Buspirone in Reducing Shortness of Breath in Patients With Cancer buspirone hydrochloride, Placebo - Dyspnea, Pulmonary Complications | Phase 2 / Phase 3 | Completed | University of Rochester | 432 | 2002-11-01 | 2015-11-24 |
Schizophrenia (2) · Anxiety Disorders (1) · Autistic Disorder (1) · Dementia (1) · Depression (1) · Dyspnea (1) · Generalized Anxiety Disorder (1) · Heart Failure (1) · Hypothermia (1) · Ischemic Stroke (1) · Parkinson Disease (1) · Primary Dysautonomias (1) · Psychophysiologic Disorders (1) · Psychotic Disorders (1) · Sleep Apnea, Central (1)
Assistance Publique - Hôpitaux de Paris (1) · Beijing Union Pharmaceutical Factory Ltd (1) · Chugani, Diane C. (1) · Hannover Medical School (1) · Northwestern University (1) · University of Erlangen-Nürnberg Medical School (1) · University of Rochester (1) · VA Office of Research and Development (1) · Valenta Pharm JSC (1)
United States (4) · Germany (2) · China (1) · France (1) · Russia (1)
Diane C Chugani, PhD (1) · Helge Frieling, Prof., MD (1) · Herbert Y Meltzer, M.D. (1) · Kingman P. Strohl, MD (1) · Peter Bushunow, MD (1) · Stefan Schwab, Prof (1)
PMID 24828363, PMID 26746121, PMID 29187242, PMID 31356217, PMID 37811711
2015 (1), U01NS061264 (1), U10CA037420 (1)